4D Molecular Therapeutics Holds Annual Stockholder Meeting
Ticker: FDMT · Form: 8-K · Filed: Jun 20, 2025 · CIK: 1650648
| Field | Detail |
|---|---|
| Company | 4d Molecular Therapeutics, INC. (FDMT) |
| Form Type | 8-K |
| Filed Date | Jun 20, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: stockholder-meeting, corporate-governance
TL;DR
4D Molecular Therapeutics stockholders met, voted on directors and auditors.
AI Summary
On June 17, 2025, 4D Molecular Therapeutics, Inc. filed an 8-K report to announce the results of its annual meeting of stockholders. The company's stockholders voted on several proposals, including the election of directors and the ratification of the appointment of its independent registered public accounting firm.
Why It Matters
This filing provides transparency on shareholder voting outcomes, which can indicate investor confidence and influence future corporate decisions.
Risk Assessment
Risk Level: low — This is a routine filing reporting on the results of an annual stockholder meeting, with no new material financial or operational information.
Key Players & Entities
- 4D Molecular Therapeutics, Inc. (company) — Registrant
- June 17, 2025 (date) — Date of earliest event reported
- Delaware (jurisdiction) — State of Incorporation
- 5858 Horton Street #455 (address) — Principal Executive Offices
- Emeryville, California (location) — Principal Executive Offices City and State
- 94608 (zip_code) — Principal Executive Offices Zip Code
- (510) 505-2680 (phone_number) — Registrant's Telephone Number
FAQ
What was the primary purpose of the 8-K filing by 4D Molecular Therapeutics, Inc. on June 20, 2025?
The primary purpose was to report on the submission of matters to a vote of security holders, specifically the results of their annual meeting of stockholders held on June 17, 2025.
When was the earliest event reported in this 8-K filing?
The earliest event reported was on June 17, 2025.
Where is 4D Molecular Therapeutics, Inc. incorporated?
4D Molecular Therapeutics, Inc. is incorporated in Delaware.
What is the business address of 4D Molecular Therapeutics, Inc. as listed in the filing?
The business address is 5858 Horton Street #455, Emeryville, California, 94608.
What is the IRS Employer Identification Number for 4D Molecular Therapeutics, Inc.?
The IRS Employer Identification Number is 47-3506994.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on June 20, 2025 regarding 4D Molecular Therapeutics, Inc. (FDMT).